MALAT1 in Liquid Biopsy: The Diagnostic and Prognostic Promise for Colorectal Cancer and Adenomas?

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Siskova A, Cervena K, Kral J, et al. Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers. Int J Mol Sci. 2020;21(9):3260. doi:10.3390/ijms21093260
   PubMed Web of Science ®Google Scholar
• Rubio CA, Jaramillo E, Lindblom A, et al. Classification of colorectal polyps: guidelines for the endoscopist. Endoscopy. 2002;34(3):226–236. doi:10.1055/s-2002-20296
   PubMed Web of Science ®Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767. doi:10.1016/0092-8674(90)90186-I
   PubMed Web of Science ®Google Scholar
• Allescher HD, Weingart V. Optimizing Screening Colonoscopy: strategies and Alternatives. Visc Med. 2019;35(4):215–225. doi:10.1159/000501835
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges. World J Gastroenterol. 2019;25(2):190–204. doi:10.3748/wjg.v25.i2.190
   PubMed Web of Science ®Google Scholar
• Gonzalez-Kozlova EE. Molecular Profiling of Liquid Biopsies for Precision Oncology. Adv Exp Med Biol. 2022;1361:235–247.
   PubMedGoogle Scholar
• Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic - implementation issues and future challenges. Nat Rev Clin Oncol. 2021;18(5):297–312. doi:10.1038/s41571-020-00457-x
   PubMed Web of Science ®Google Scholar
• Lone SN, Nisar S, Masoodi T, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022;21(1):79. doi:10.1186/s12943-022-01543-7
   PubMed Web of Science ®Google Scholar
• Cervena K, Pardini B, Urbanova M, et al. Mutational landscape of plasma cell-free DNA identifies molecular features associated with therapeutic response in patients with colon cancer. A pilot study. Mutagenesis. 2021;36(5):358–368. doi:10.1093/mutage/geab024
   PubMed Web of Science ®Google Scholar
• Suraj S, Dhar C, Srivastava S. Circulating nucleic acids: an analysis of their occurrence in malignancies. Biomed Rep. 2017;6(1):8–14. doi:10.3892/br.2016.812
   PubMedGoogle Scholar
• Szilagyi M, Pös O, Márton É, et al. Circulating Cell-Free Nucleic Acids: main Characteristics and Clinical Application. Int J Mol Sci. 2020;21(18):6827. doi:10.3390/ijms21186827
   PubMed Web of Science ®Google Scholar
• Brannan CI, Dees EC, Ingram RS, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990;10(1):28–36. doi:10.1128/mcb.10.1.28-36.1990
   PubMed Web of Science ®Google Scholar
• Kosinska-Selbi B, Mielczarek M, Szyda J. Review: long non-coding RNA in livestock. Animal. 2020;14(10):2003–2013. doi:10.1017/S1751731120000841
   PubMed Web of Science ®Google Scholar
• Cervena K, Vodenkova S, Vymetalkova V. MALAT1 in colorectal cancer: its implication as a diagnostic, prognostic, and predictive biomarker. Gene. 2022;843:146791. doi:10.1016/j.gene.2022.146791
   PubMed Web of Science ®Google Scholar
• Siskova A, Kral J, Drabova J, et al. Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions. Int J Mol Sci. 2022;23(14):7656. doi:10.3390/ijms23147656
   PubMed Web of Science ®Google Scholar
• Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041. doi:10.1038/sj.onc.1206928
   PubMed Web of Science ®Google Scholar
• Chaleshi V, Irani S, Alebouyeh M, et al. Association of lncRNA-p53 regulatory network (lincRNA-p21, lincRNA-ROR and MALAT1) and p53 with the clinicopathological features of colorectal primary lesions and tumors. Oncol Lett. 2020;19(6):3937–3949. doi:10.3892/ol.2020.11518
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang X, Hu X, et al. The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Mol Med. 2018;24(1):52. doi:10.1186/s10020-018-0050-5
   PubMed Web of Science ®Google Scholar
• Schlemper RJ, Riddell RH, Kato YE, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47(2):251–255. doi:10.1136/gut.47.2.251
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–7. doi:10.1093/nar/gkt1248
   PubMed Web of Science ®Google Scholar
• Li J, Ma W, Zeng P, et al. LncTar: a tool for predicting the RNA targets of long noncoding RNAs. Brief Bioinform. 2015;16(5):806–812. doi:10.1093/bib/bbu048
   PubMed Web of Science ®Google Scholar
• Mi H, Thomas P. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol. 2009;563:123–140.
   PubMedGoogle Scholar
• He J, Wu F, Han Z, et al. Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer - From the Body Fluid to Tissue Level. Front Oncol. 2021;11:632834. doi:10.3389/fonc.2021.632834
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Hur K, et al. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis. 2014;35(12):2731–2739. doi:10.1093/carcin/bgu200
   PubMed Web of Science ®Google Scholar
• Pang EJ, Yang R, Fu X-B, et al. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol. 2015;36(4):2403–2407. doi:10.1007/s13277-014-2850-8
   PubMedGoogle Scholar
• Yue X, Wu W-Y, Dong M, et al. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p. Biomed J. 2021;44(6 Suppl 2):S296–S304. doi:10.1016/j.bj.2020.11.002
   PubMed Web of Science ®Google Scholar
• Arun G, Aggarwal D, Spector DL. MALAT1 Long Non-Coding RNA: functional Implications. Noncoding RNA. 2020;6(2). doi:10.3390/ncrna6020022
   PubMed Web of Science ®Google Scholar
• Tripathi V, Ellis JD, Shen Z, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925–938. doi:10.1016/j.molcel.2010.08.011
   PubMed Web of Science ®Google Scholar
• Yang L, Lin C, Liu W, et al. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011;147(4):773–788. doi:10.1016/j.cell.2011.08.054
   PubMed Web of Science ®Google Scholar
• Su X, Xing J, Wang Z, et al. microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chin J Cancer Res. 2013;25(2):235–239. doi:10.3978/j.issn.1000-9604.2013.03.08
   PubMed Web of Science ®Google Scholar
• Tang Y, Xiao G, Chen Y, et al. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Anticancer Drugs. 2018;29(8):725–735. doi:10.1097/CAD.0000000000000650
   PubMed Web of Science ®Google Scholar
• Xie JJ, Li WH, Li X, et al. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression. J Biol Regul Homeost Agents. 2019;33(2):331–343.
   PubMed Web of Science ®Google Scholar
• Guo J, Ding Y, Yang H, et al. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging. Exp Mol Pathol. 2020;115:104448. doi:10.1016/j.yexmp.2020.104448
   PubMed Web of Science ®Google Scholar
• Ji Q, Cai G, Liu X, et al. MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis. Cell Death Dis. 2019;10(6):378. doi:10.1038/s41419-019-1598-x
   PubMedGoogle Scholar
• Liu Y, Yin Z, Lu P, et al. Lung Carcinoma Cells Secrete Exosomal MALAT1 to Inhibit Dendritic Cell Phagocytosis, Inflammatory Response, Costimulatory Molecule Expression and Promote Dendritic Cell Autophagy via AKT/mTOR Pathway. Onco Targets Ther. 2020;13:10693–10705. doi:10.2147/OTT.S256669
   PubMed Web of Science ®Google Scholar
• Hewitson JP, West KA, James KR, et al. Malat1 Suppresses Immunity to Infection through Promoting Expression of Maf and IL-10 in Th Cells. J Immunol. 2020;204(11):2949–2960. doi:10.4049/jimmunol.1900940
   PubMed Web of Science ®Google Scholar
• Zhao G, Su Z, Song D, et al. The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-kappaB. FEBS Lett. 2016;590(17):2884–2895. doi:10.1002/1873-3468.12315
   PubMed Web of Science ®Google Scholar
• Wang QM, Lian G-Y, Song Y, et al. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335. doi:10.1016/j.lfs.2019.03.040
   PubMed Web of Science ®Google Scholar
• Sun Z, Ou C, Liu J, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2019;38(14):2627–2644. doi:10.1038/s41388-018-0628-y
   PubMed Web of Science ®Google Scholar
• Matheu A, Collado M, Wise C, et al. Oncogenicity of the developmental transcription factor Sox9. Cancer Res. 2012;72(5):1301–1315. doi:10.1158/0008-5472.CAN-11-3660
   PubMed Web of Science ®Google Scholar
• Lu B, Fang Y, Xu J, et al. Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol. 2008;130(6):897–904. doi:10.1309/AJCPW1W8GJBQGCNI
   PubMed Web of Science ®Google Scholar
• Lizarraga-Verdugo E, Carmona T, Ramos-Payan R, et al. SOX9 is associated with advanced T-stages of clinical stage II colon cancer in young Mexican patients. Oncol Lett. 2021;22(1):497. doi:10.3892/ol.2021.12758
   PubMed Web of Science ®Google Scholar
• Szulzewsky F, Holland EC, Vasioukhin V. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev Biol. 2021;475:205–221. doi:10.1016/j.ydbio.2020.12.018
   PubMed Web of Science ®Google Scholar
• Jass JR. Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol Clin North Am. 2007;36(4):927–46, viii. doi:10.1016/j.gtc.2007.08.009
   PubMed Web of Science ®Google Scholar
• Zheng HT, Shi D-B, Wang Y-W, et al. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol. 2014;7(6):3174–3181.
   PubMed Web of Science ®Google Scholar
• Wu X, Li R, Song Q, et al. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing beta-catenin signaling pathway. J Exp Clin Cancer Res. 2019;38(1):435. doi:10.1186/s13046-019-1439-x
   PubMed Web of Science ®Google Scholar
• Li Q, Dai Y, Wang F, et al. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer. Neoplasma. 2016;63(6):977–983. doi:10.4149/neo_2016_617
   PubMed Web of Science ®Google Scholar
• Li P, Zhang X, Wang H, et al. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2. Mol Cancer Ther. 2017;16(4):739–751. doi:10.1158/1535-7163.MCT-16-0591
   PubMed Web of Science ®Google Scholar
• Fan C, Yuan Q, Liu G, et al. Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p/ADAM17 axis in colorectal cancer cells. Cancer Cell Int. 2020;20(1):473. doi:10.1186/s12935-020-01549-5
   PubMed Web of Science ®Google Scholar
• Kyula JN, Van Schaeybroeck S, Doherty J, et al. Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancer. Clin Cancer Res. 2010;16(13):3378–3389. doi:10.1158/1078-0432.CCR-10-0014
   PubMed Web of Science ®Google Scholar
• Siddique H, Al-Ghafari A, Choudhry H, et al. Long Noncoding RNAs as Prognostic Markers for Colorectal Cancer in Saudi Patients. Genet Test Mol Biomarkers. 2019;23(8):509–514. doi:10.1089/gtmb.2018.0308
   PubMed Web of Science ®Google Scholar
• Radwan AF, Shaker OG, El-Boghdady NA, et al. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: correlation with Epithelial-Mesenchymal Transition. Int J Mol Sci. 2021;22(11):6147. doi:10.3390/ijms22116147
   PubMed Web of Science ®Google Scholar
• Li Y, Bao C, Gu S, et al. Associations between novel genetic variants in the promoter region of MALAT1 and risk of colorectal cancer. Oncotarget. 2017;8(54):92604–92614. doi:10.18632/oncotarget.21507
   PubMedGoogle Scholar
• Zhao K, Jin S, Wei B, et al. Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer. Cancer Manag Res. 2018;10:6257–6261. doi:10.2147/CMAR.S177244
   PubMed Web of Science ®Google Scholar
• Yang Q, Zheng W, Shen Z, et al. MicroRNA Binding Site Polymorphisms of the Long-Chain Noncoding RNA MALAT1 are Associated with Risk and Prognosis of Colorectal Cancer in Chinese Han Population. Genet Test Mol Biomarkers. 2020;24(5):239–248. doi:10.1089/gtmb.2020.0013
   PubMed Web of Science ®Google Scholar
• Wu S, Sun H, Wang Y, et al. MALAT1 rs664589 Polymorphism Inhibits Binding to miR-194-5p, Contributing to Colorectal Cancer Risk, Growth, and Metastasis. Cancer Res. 2019;79(20):5432–5441. doi:10.1158/0008-5472.CAN-19-0773
   PubMed Web of Science ®Google Scholar